Skip to main content

Table 2 The clinical characteristics of the 29 patients

From: Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?

Factors

All patients

PD (nā€‰=ā€‰8)

Non-PD (nā€‰=ā€‰21)

p values

Age (years old) (meanā€‰Ā±ā€‰S.D.) (range)

62.4ā€‰Ā±ā€‰15.4 (26ā€“81)

72.0ā€‰Ā±ā€‰6.0 (65ā€“81)

58.6ā€‰Ā±ā€‰16.5 (26ā€“81)

0.035

Gender

0.481

ā€ƒMale

12 (41.4%)

4 (13.8%)

8 (27.6%)

Ā 

ā€ƒFemale

17 (58.6%)

4 (13.8%)

13 (44.9%)

Ā 

Histology

1.000

ā€ƒPapillary

21 (72.4%)

6 (20.6%)

15 (51.7%)

Ā 

ā€ƒFollicular

8 (27.6%)

2 (7.0%)

6 (20.6%)

Ā 

Serum glucose level (mg/dl) (meanā€‰Ā±ā€‰S.D.) (range)

110.1ā€‰Ā±ā€‰26.2 (84ā€“204)

115.0ā€‰Ā±ā€‰29.9 (84ā€“204)

109.1ā€‰Ā±ā€‰25.5 (92ā€“175)

0.633

Number of measurable lesions (maxā€‰=ā€‰5)

0.104

ā€ƒOne

18 (62.1%)

4 (13.8%)

14 (49.3%)

Ā 

ā€ƒTwo

6 (20.6%)

1 (3.4%)

5 (17.2%)

Ā 

ā€ƒThree

4 (13.8%)

2 (7.0%)

2 (7.0%)

Ā 

ā€ƒFour

1 (3.4%)

1 (3.4%)

0 (0%)

Ā 

Position of metastatic lesions

0.971

ā€ƒLung

18 (39.1%)

6 (13.0%)

12 (26.1%)

Ā 

ā€ƒLymph nodes

16 (34.8%)

6 (13.0%)

10 (21.7%)

Ā 

ā€ƒBone

8 (17.4%)

3 (6.5%)

5 (11.0%)

Ā 

ā€ƒLiver

2 (4.3%)

0 (0%)

2 (4.3%)

Ā 

ā€ƒPeritoneum

2 (4.3%)

0 (0%)

2 (4.3%)

Ā 

Cycle of therapy

Ā Ā Ā 

0.630

ā€ƒOne

17 (58.5%)

4 (13.8%)

13 (44.9%)

Ā 

ā€ƒTwo

8 (17.4%)

2 (7.0%)

6 (20.6%)

Ā 

ā€ƒThree

1 (3.4%)

0 (0%)

1 (3.4%)

Ā 

ā€ƒMore than three

3 (6.5%)

2 (7.0%)

1 (3.4%)

Ā 

Activity of RAI (GBq, meanā€‰Ā±ā€‰S.D.) (range)

3.2ā€‰Ā±ā€‰1.2 (1.1ā€“5.6)

3.4ā€‰Ā±ā€‰1.1 (1.1ā€“5.6)

3.1ā€‰Ā±ā€‰1.2 (1.1ā€“5.6)

0.940

Total activity of RAI (GBq, meanā€‰Ā±ā€‰S.D.) (range)

23.9ā€‰Ā±ā€‰25.2 (1.1ā€“37.0)

15.7ā€‰Ā±ā€‰17.1 (1.1ā€“34.0)

18.2ā€‰Ā±ā€‰16.8 (1.1ā€“37.0)

0.982

Tg before therapy (range)

1784.2ā€‰Ā±ā€‰4975.4 (0ā€“24,892.4)

4032.7ā€‰Ā±ā€‰8761.9 (4.42ā€“24,892.4)

884.8ā€‰Ā±ā€‰1978.4 (0ā€“8610)

0.709

Change of Tg (range)

āˆ’0.3ā€‰Ā±ā€‰0.6 (āˆ’ā€‰1.0ā€“0.8)

1.0ā€‰Ā±ā€‰0.6 (āˆ’ā€‰1ā€“0.8)

āˆ’0.5ā€‰Ā±ā€‰0.5 (āˆ’ā€‰1ā€“0.4)

0.042

RECIST evaluation after RAI (months)

10.2ā€‰Ā±ā€‰1.7

10.8ā€‰Ā±ā€‰0.9

9.9ā€‰Ā±ā€‰1.3

1.000